Phibro CFO gets 3,482 RSUs in amended grant

Phibro Animal Health’s CFO received 3,482 RSUs in an equity grant, correcting an earlier understated Form 4 report.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

PHIBRO ANIMAL HEALTH CORP (symbol: PAHC) is the issuer of record for a Form 4/A filing submitted to the SEC. David Glenn reported acquisition or exercise transactions in this Form 4 filing.

PHIBRO ANIMAL HEALTH CORP (PAHC) reported that its Chief Financial Officer, David Glenn, received a grant of 3,482 restricted stock units (RSUs) on August 6, 2026, each representing one share of Class A Common Stock. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment. This Form 4/A amends a prior report to correct an understated RSU grant amount, and shows Glenn holding 54,959 Class A shares directly after the grant.

Insider Trade Summary

Grant/Award: 3,482 shares

Grant/Award 1 txn

Insider David Glenn

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2, F3	3,482	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 54,959 shares (Direct)

Footnotes (3)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
3. F3. This amendment to the Form 4 filed on August 10, 2026 (the "Original Form 4") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026.

Key Figures

RSUs granted: 3,482 RSUs Shares per RSU: 1 share of Class A Common Stock Vesting schedule: 3 substantially equal annual installments +2 more

5 metrics

RSUs granted 3,482 RSUs Grant of restricted stock units to CFO David Glenn on August 6, 2026

Shares per RSU 1 share of Class A Common Stock Each RSU represents a contingent right to receive one share

Vesting schedule 3 substantially equal annual installments RSUs vest on each of the first three anniversaries of August 1, 2026

Shares held after transaction 54,959 shares Direct Class A Common Stock holdings of David Glenn following the grant

Original Form 4 filing date August 10, 2026 Date of the original Form 4 that understated the RSU grant

Key Terms

restricted stock units, contingent right, vest, Form 4

4 terms

restricted stock units financial

"The reported securities represent restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"each of which represents a contingent right to receive one share"

vest financial

"The RSUs vest in substantially equal installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Form 4 regulatory

"amendment to the Form 4 filed on August 10, 2026"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PAHC report for its CFO in this Form 4/A?

Phibro Animal Health reported that its Chief Financial Officer, David Glenn, received a grant of 3,482 RSUs on August 6, 2026, each RSU representing a contingent right to one share of Class A Common Stock.

How do the 3,482 RSUs granted to the PAHC CFO vest?

The 3,482 RSUs granted to Phibro Animal Health’s CFO vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment through each vesting date.

What does the Form 4/A amendment change for PAHC’s CFO grant?

The amendment states that the original Form 4 filed August 10, 2026 understated the number of RSUs granted on August 6, 2026 due to a calculation error. The 3,482 RSUs now reported are described as the correct grant amount.

How many PAHC Class A shares does the CFO hold after this RSU grant?

After the reported RSU grant, David Glenn is shown as holding 54,959 shares of Phibro Animal Health Class A Common Stock directly, as reported in the Form 4/A.

Was the PAHC CFO’s RSU grant made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating the RSU grant was made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 05:33 PM Accepted by SEC EDGAR 09/17/2026 - 05:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

David Glenn

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/10/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		3,482(2)(3)	A	$0	54,959	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

3. This amendment to the Form 4 filed on August 10, 2026 (the "Original Form 4") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026.

	/s/ Judith Weinstein, as Attorney-in-Fact for Glenn David	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)